Yesterday, Peregrine Pharmaceuticals (NASDAQ:PPHM) hosted a conference call to discuss its financial first quarter results for 2017, with the three-month quarter having ended …
In a research report issued Friday, FBR analyst Thomas Yip reiterated an Outperform rating on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), with a $1.00 price target, …
Omeros Corporation (NASDAQ:OMER) shot up more than 60% in pre-market trading on Tuesday after the pharmaceutical company announced additional positive data for OMS721 …
MLV’s healthcare analyst Thomas Yip weighed in with a few insights on Geron Corporation (NASDAQ:GERN), following the company’s second-quarter results and update on its clinical …
In a research report released Tuesday, MLV analyst Thomas Yip reiterated a Buy rating on shares of OXiGENE Inc (NASDAQ:OXGN) with a price target …
Thomas Yip, equity research analyst at MLV & Co., weighed in today with a favorable report on Threshold Pharmaceuticals, Inc.
In a research report issued today, MLV analyst Thomas Yip maintained a Buy rating on Peregrine Pharma (NASDAQ:PPHM) with a price target of …
MLV’s healthcare analyst Thomas Yip weighed in today with a few insights on OXiGENE Inc (NASDAQ:OXGN), after the company announced the basic design of an upcoming …
In a research report issued today, MLV analyst Thomas Yip reiterated a Buy rating on Peregrine Pharmaceuticals (NASDAQ:PPHM) with a $3.50 price target, after …
MLV analyst Thomas Yip came out with a few insights on Geron Corporation (NASDAQ:GERN) after the company reported its first-quarter results and update on …
